The open-source AI model improves transparency in predicting how proteins interact with other molecules, which could speed up drug discovery.
Worried about your business's data? Apriel 2.0 is aimed at federal agencies and tightly regulated industries like healthcare and finance that want AI agents with less risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback